Clinical trial
Yellow Fever Vaccine in Patients With Rheumatic Diseases
NCT03430388
Study timeline
Study start (actual)2018-01-31Date precision: day
Registry last updated2019-04-26
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Systemic Lupusunresolved
Rheumatoid Arthritisunresolved
Spondyloarthritisunresolved
Inflammatory Myopathyunresolved
Systemic Sclerosisunresolved
Mixed Connective Tissue Diseaseunresolved
Takayasu Arteritisunresolved
Granulomatosis With Polyangiitisunresolved
Sjogren's Syndromeunresolved
Juvenile Idiopathic Arthritisunresolved
Juvenile Dermatomyositisunresolved
Interventions
Yellow Fever vaccine (17D)BIOLOGICAL
Sponsors & collaborators
University of Sao Paulo General Hospitallead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03430388 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.